CGON Annual EBIT
-$55.45 M
-$20.20 M-57.32%
31 December 2023
Summary:
As of January 19, 2025, CGON annual earnings before interest & taxes is -$55.45 million, with the most recent change of -$20.20 million (-57.32%) on December 31, 2023. During the last 3 years, it has fallen by -$43.06 million (-347.60%). CGON annual EBIT is now -347.60% below its all-time high of -$12.38 million.CGON EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CGON Quarterly EBIT
-$28.30 M
-$2.44 M-9.45%
30 September 2024
Summary:
As of January 19, 2025, CGON quarterly earnings before interest & taxes is -$28.30 million, with the most recent change of -$2.44 million (-9.45%) on September 30, 2024. Over the past year, it has dropped by -$5.83 million (-25.93%). CGON quarterly EBIT is now -203.76% below its all-time high of -$9.31 million, reached on December 1, 2022.CGON Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CGON TTM EBIT
-$95.97 M
-$14.25 M-17.44%
30 September 2024
Summary:
As of January 19, 2025, CGON TTM earnings before interest & taxes is -$95.97 million, with the most recent change of -$14.25 million (-17.44%) on September 30, 2024. Over the past year, it has dropped by -$27.78 million (-40.74%). CGON TTM EBIT is now -930.30% below its all-time high of -$9.31 million, reached on December 1, 2022.CGON TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CGON EBIT Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -57.3% | -25.9% | -40.7% |
3 y3 years | -347.6% | -129.6% | -206.0% |
5 y5 years | -347.6% | -129.6% | -206.0% |
CGON EBIT High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -347.6% | at low | -203.8% | at low | -930.3% | at low |
5 y | 5-year | -347.6% | at low | -203.8% | at low | -930.3% | at low |
alltime | all time | -347.6% | at low | -203.8% | at low | -930.3% | at low |
CG Oncology EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$28.30 M(+9.4%) | -$95.97 M(+17.4%) |
June 2024 | - | -$25.85 M(+15.1%) | -$81.72 M(+19.8%) |
Mar 2024 | - | -$22.47 M(+16.1%) | -$68.19 M(+23.0%) |
Dec 2023 | -$55.45 M | -$19.36 M(+37.8%) | -$55.45 M(+22.1%) |
Sept 2023 | - | -$14.04 M(+13.9%) | -$45.41 M(+44.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2023 | - | -$12.33 M(+26.8%) | -$31.36 M(+64.8%) |
Mar 2023 | - | -$9.72 M(+4.4%) | -$19.04 M(+104.4%) |
Dec 2022 | -$35.25 M(+184.5%) | - | - |
Dec 2022 | - | -$9.31 M | -$9.31 M |
Dec 2021 | -$12.39 M | - | - |
FAQ
- What is CG Oncology annual earnings before interest & taxes?
- What is the all time high annual EBIT for CG Oncology?
- What is CG Oncology annual EBIT year-on-year change?
- What is CG Oncology quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for CG Oncology?
- What is CG Oncology quarterly EBIT year-on-year change?
- What is CG Oncology TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for CG Oncology?
- What is CG Oncology TTM EBIT year-on-year change?
What is CG Oncology annual earnings before interest & taxes?
The current annual EBIT of CGON is -$55.45 M
What is the all time high annual EBIT for CG Oncology?
CG Oncology all-time high annual earnings before interest & taxes is -$12.38 M
What is CG Oncology annual EBIT year-on-year change?
Over the past year, CGON annual earnings before interest & taxes has changed by -$20.20 M (-57.32%)
What is CG Oncology quarterly earnings before interest & taxes?
The current quarterly EBIT of CGON is -$28.30 M
What is the all time high quarterly EBIT for CG Oncology?
CG Oncology all-time high quarterly earnings before interest & taxes is -$9.31 M
What is CG Oncology quarterly EBIT year-on-year change?
Over the past year, CGON quarterly earnings before interest & taxes has changed by -$5.83 M (-25.93%)
What is CG Oncology TTM earnings before interest & taxes?
The current TTM EBIT of CGON is -$95.97 M
What is the all time high TTM EBIT for CG Oncology?
CG Oncology all-time high TTM earnings before interest & taxes is -$9.31 M
What is CG Oncology TTM EBIT year-on-year change?
Over the past year, CGON TTM earnings before interest & taxes has changed by -$27.78 M (-40.74%)